Study: Weight loss drugs can reduce cancer risk by 41%
⚡ Quick Summary
Research is the first to exclusively evaluate the relationship between GLP-1 receptor agonists and obesity-associated tumors in people without diabetes
🗞️ 1 sources covered this story
📰 Related Articles
Neo-Nazi is almost elected mayor in Germany
CartaCapital
Strong earthquake shakes Havana
CartaCapitalGilberto Natalini participates in the live “Environment, Climate and Health”, from SES-SP - APM
APM - Associação Paulista de Medicina
Dengue: Health suspends use of Butantan vaccine while investigating adverse events
CartaCapital
How veterinary medicine and animal behavior science help consultants understand 'feline enigmas'
BBC Brasil